The CBD Nutraceuticals Market 🌿, valued at USD 3.8 Billion in 2022, is projected to reach USD 16.9 Billion by 2032 with a Compound Annual Growth Rate (CAGR) of 16.3% πŸ’Ό. CBD, derived from the cannabis sativa plant, is renowned for its medicinal properties, treating conditions like epilepsy, pain, and Parkinson's disease. Unlike THC, hashtag#CBD is non-psychoactive and is increasingly integrated into nutraceuticals for its health benefits. Rising awareness of CBD's potential health advantages, coupled with the growing focus on maintaining healthy lifestyles, fuels market growth πŸ“ˆ. Notably, CBD products are popular for alleviating anxiety, improving sleep, and reducing stress, with over half of respondents in a Forbes Health Survey reporting CBD use for these purposes. 🌱

Posted by ICBC - InternationalCBC at 2024-02-22 01:22:51 UTC